Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works

Stem cells, cancer, and cancer stem cells

Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738 · see citing works

Identification of human brain tumour initiating cells

Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,388 · see citing works

Identification of a cancer stem cell in human brain tumors.

Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C. E., Squire, J. A., & Dirks, P. B. (2003) · PubMed · Cited by 4,861 · see citing works

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783 · see citing works

Calreticulin exposure dictates the immunogenicity of cancer cell death

Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216 · see citing works

Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,797 · see citing works

CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752 · see citing works

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578 · see citing works

A blast from the past: clearance of apoptotic cells regulates immune responses

Savill, J., Dransfield, I., Gregory, C. D., & Haslett, C. (2002) · Nature reviews. Immunology · doi:10.1038/nri957 · Cited by 1,574 · see citing works

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 12× · see citing works

Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the Phagocyte

Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473 · see citing works

Immune surveillance of tumors

Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,469 · see citing works

Cancer despite immunosurveillance: immunoselection and immunosubversion

Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324 · see citing works

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

Chao, M. P., Alizadeh, A. A., Tang, C. Z., Myklebust, J. H., Varghese, B., Gill, S. I., Jan, M., Cha, A. C., Chan, C. K. F., Tan, B. T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.044 · Cited by 1,095 · see citing works

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Rosenwald, A., Wright, G. W., Wiestner, A. U., Chan, W. C., Connors, J. M., Campo, E., Gascoyne, R. D., Grogan, T. M., Müller-Hermelink, H. K., Smeland, E. B., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00028-x · Cited by 905 · see citing works

Surface exposure of phosphatidylserine in pathological cells

Zwaal, R. F. A., Comfurius, P., & Bevers, E. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4527-3 · Cited by 753 · see citing works

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

Chan, K. S., Espinosa, Í., Chao, M. P., Wong, D. J., Ailles, L., Diehn, M., Gill, H. S., Presti, J. C., Chang, H. Y., van de Rijn, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906549106 · Cited by 658 · see citing works

Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes.

Utsugi, T., Schroit, A. J., Connor, J., Bucana, C. D., & Fidler, I. J. (1991) · PubMed · Cited by 594 · see citing works

Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

Obeid, M., Panaretakis, T., Joza, N., Tufi, R., Tesniere, A., van Endert, P., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402201 · Cited by 474 · see citing works

The SIRP family of receptors and immune regulation

Barclay, A. N., & Brown, M. H. (2006) · Nature reviews. Immunology · doi:10.1038/nri1859 · Cited by 427 · see citing works

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

Kim, W., Kim, E., Kim, S., Kim, Y., Ha, Y., Jeong, P., Kim, M.-J., Yun, S. J., Lee, K. M., Moon, S., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-3 · Cited by 403 · see citing works

Annexin 1: the new face of an old molecule

Lim, L. H. K., & Pervaiz, S. (2007) · The FASEB Journal · doi:10.1096/fj.06-7464rev · Cited by 399 · see citing works

Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion

Coppolino, M. G., Woodside, M. J., Demaurex, N., Grinstein, S., St‐Arnaud, R., & Dedhar, S. (1997) · Nature · doi:10.1038/386843a0 · Cited by 392 · see citing works

Integrin-associated Protein Is a Ligand for the P84 Neural Adhesion Molecule

Jiang, P., Lagenaur, C. F., & Narayanan, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.559 · Cited by 353 · see citing works

The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death

Panaretakis, T., Joza, N., Modjtahedi, N., Tesniere, A., Vitale, I., Durchschlag, M., Fimia, G. M., Kepp, O., Piacentini, M., Froehlich, K.-U., et al. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.67 · Cited by 344 · see citing works

Lack of Expression of Thy-1 (CD90) on Acute Myeloid Leukemia Cells With Long-Term Proliferative Ability In Vitro and In Vivo

Blair, A., Hogge, D. E., Ailles, L. E., Lansdorp, P. M., & Sutherland, H. J. (1997) · Blood · doi:10.1182/blood.v89.9.3104 · Cited by 335 · see citing works

Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth

Pike, S. E., Yao, L., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H. L., Teruya‐Feldstein, J., Wirth, P. J., Gupta, G., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2349 · Cited by 310 · see citing works

LDL receptor‐related protein: a multiligand receptor for lipoprotein and proteinase catabolism

Strickland, D. K., Kounnas, M. Z., & Argraves, W. S. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615159 · Cited by 268 · see citing works

Macrophages as mediators of tumor immunosurveillance

Jaiswal, S., Chao, M. P., Majeti, R., & Weissman, I. L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.04.001 · Cited by 241 · see citing works

In vivo expression of alternatively spliced forms of integrin-associated protein (cd47)

Reinhold, M. I., Lindberg, F. P., Plas, D. R., Reynolds, S., Peters, M. G., & Brown, E. J. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.11.3419 · Cited by 233 · see citing works

Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer

Als, A. B., Dyrskjøt, L., von der Maase, H., Koed, K., Mansilla, F., Toldbod, H., Jensen, J. L., Ulhøi, B. P., Sengeløv, L., Jensen, K. M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0109 · Cited by 206 · see citing works

Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation.

Connor, J., BUCANA, C. D., Fidler, I. J., & Schroit, A. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3184 · Cited by 186 · see citing works

Calreticulin and Calreticulin Fragments Are Endothelial Cell Inhibitors That Suppress Tumor Growth

Pike, S. E., Yao, L., Setsuda, J., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H. L., Atreya, C. D., Teruya‐Feldstein, J., et al. (1999) · Blood · doi:10.1182/blood.v94.7.2461.419a26_2461_2468 · Cited by 177 · see citing works

Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling

Maxhimer, J. B., Soto‐Pantoja, D. R., Ridnour, L. A., Shih, H. B., DeGraff, W., Tsokos, M., Wink, D. A., Isenberg, J. S., & Roberts, D. D. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000139 · Cited by 176 · see citing works

Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration

Orr, A. W., Elzie, C. A., Kucik, D. F., & Murphy-Ullrich, J. E. (2003) · Journal of Cell Science · doi:10.1242/jcs.00600 · Cited by 174 · see citing works

Low density lipoprotein receptor–related protein is a calreticulin coreceptor that signals focal adhesion disassembly

Orr, A. W., Pedraza, C. E., Pallero, M. A., Elzie, C. A., Goicoechea, S. M., Strickland, D. K., & Murphy-Ullrich, J. E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302069 · Cited by 168 · see citing works

Self inhibition of phagocytosis: The affinity of ‘marker of self’ CD47 for SIRPα dictates potency of inhibition but only at low expression levels

Tsai, R. K., Rodriguez, P. L., & Discher, D. E. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.02.016 · Cited by 143 · see citing works

Calreticulin Is Expressed on the Cell Surface of Activated Human Peripheral Blood T Lymphocytes in Association with Major Histocompatibility Complex Class I Molecules

Arosa, F. A., de Jesus, O., Porto, G., Carmo, A. M., & de Sousa, M. A. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16917 · Cited by 135 · see citing works

Identification of Calreticulin as a Prognosis Marker and Angiogenic Regulator in Human Gastric Cancer

Chen, C., Chang, C.-C., Su, T., Hsu, W., Jeng, Y., Ho, M., Hsieh, F., Lee, P., Kuo, M., Lee, H., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0243-1 · Cited by 130 · see citing works

Dissection of receptor folding and ligand-binding property with functional minireceptors of LDL receptor-related protein

Obermoeller, L. M., Li, Y., Osaka, H., FitzGerald, D. J., Schwartz, A. L., & Bu, G. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.899 · Cited by 125 · see citing works

The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family

Bu, G. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)09011-8 · Cited by 120 · see citing works

PAI-1 inhibits neutrophil efferocytosis

Park, Y.-J., Liu, G., Lorne, E., Zhao, X., Wang, J., Tsuruta, Y., Zmijewski, J. W., & Abraham, E. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801394105 · Cited by 110 · see citing works

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

Preter, K. D., Vermeulen, J., Brors, B., Delattre, O., Eggert, A., Fischer, M., Janoueix‐Lerosey, I., Lavarino, C. E., Maris, J. M., Mora, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2607 · Cited by 98 · see citing works

Calreticulin‐dependent recycling in the early secretory pathway mediates optimal peptide loading of MHC class I molecules

Howe, C. M., Garstka, M. A., Al-Balushi, M. S., Ghanem, E., Antoniou, A. N., Fritzsche, S., Jankevicius, G., Kontouli, N., Schneeweiß, C., Williams, A. P., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.296 · Cited by 97 · see citing works

Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2)

Woehlecke, H., Pohl, A., Alder‐Baerens, N., Lage, H., & Herrmann, A. (2003) · Biochemical Journal · doi:10.1042/bj20030886 · Cited by 94 · see citing works

Calreticulin expression in neuroblastoma—a novel independent prognostic factor

Hsu, W., Hsieh, F. ‐., Jeng, Y., Kuo, M., Chen, C., Lai, D., Hsieh, L., Wang, B. T., Tsao, P., Lee, H., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi062 · Cited by 93 · see citing works

Calreticulin Is at the Surface of Circulating Neutrophils and Uses CD59 as an Adaptor Molecule

Ghiran, I. C., Klickstein, L. B., & Nicholson-Weller, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302306200 · Cited by 92 · see citing works

ERP57 Membrane Translocation Dictates the Immunogenicity of Tumor Cell Death by Controlling the Membrane Translocation of Calreticulin

Obéid, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2533 · Cited by 92 · see citing works

From cancer immunosurveillance to cancer immunotherapy

Stagg, J., Johnstone, R. W., & Smyth, M. J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00566.x · Cited by 88 · see citing works

Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity

Rao, L. V. M., Tait, J. F., & Hoang, A. D. (1992) · Thrombosis Research · doi:10.1016/0049-3848(92)90013-z · Cited by 84 · see citing works

Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients

Oberthuer, A., Juraeva, D., Li, L., Kahlert, Y., Westermann, F., Eils, R., Berthold, F., Shi, L. M., Wolfinger, R. D., Fischer, M., et al. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.53 · Cited by 67 · see citing works

Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis

Blenk, S., Engelmann, J. C., Pinkert, S., Weniger, M., Schultz, J., Rosenwald, A., Müller‐Hermelink, H. K., Müller, T., & Dandekar, T. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-106 · Cited by 48 · see citing works

Decreased CD47 expression during spontaneous apoptosis targets neutrophils for phagocytosis by monocyte-derived macrophages

Lawrence, D. W., King, S. B., Frazier, W. A., & Koenig, J. M. (2009) · Early Human Development · doi:10.1016/j.earlhumdev.2009.09.005 · Cited by 31 · see citing works

Gene Transfer of Vasostatin, a Calreticulin Fragment, into Neuroendocrine Tumor Cells Results in Enhanced Malignant Behavior

Liu, M., Imam, H., Öberg, K., & Zhou, Y. (2005) · Neuroendocrinology · doi:10.1159/000089749 · Cited by 15 · see citing works

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works

Immunogenic Cell Death in Cancer Therapy

Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303 · see citing works

Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>

Nangalia, J., Massie, C. E., Baxter, E. J., Nice, F. L., Gundem, G., Wedge, D. C., Avezov, E., Li, J., Kollmann, K., Kent, D. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1312542 · Cited by 1,756 · see citing works

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P. D., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R. K., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,667 · see citing works

Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice

Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377 · see citing works

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Galluzzi, L., Vitale, I., Warren, S., Adjemian, S., Agostinis, P., Buqué, A., Chan, T. A.-T., Coukos, G., Demaria, S., Deutsch, É., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000337 · Cited by 1,150 · see citing works

Apoptosis and Clearance of Apoptotic Cells

Nagata, S. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053010 · Cited by 1,107 · see citing works

Phagocytosis checkpoints as new targets for cancer immunotherapy

Feng, M., Jiang, W., Kim, B. Y. S., Zhang, C. C., Fu, Y., & Weissman, I. L. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0183-z · Cited by 914 · see citing works

Inflammatory microenvironment remodelling by tumour cells after radiotherapy

McLaughlin, M., Patin, E. C., Pedersen, M., Wilkins, A. C., Dillon, M. T., Melcher, A. A., & Harrington, K. J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0246-1 · Cited by 899 · see citing works

The clearance of dead cells by efferocytosis

Boada-Romero, E., Martinez, J., Heckmann, B. L., & Green, D. R. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0232-1 · Cited by 893 · see citing works

Consensus guidelines for the detection of immunogenic cell death

Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., et al. (2014) · OncoImmunology · doi:10.4161/21624011.2014.955691 · Cited by 832 · see citing works

The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target

Barclay, A. N., & van den Berg, T. K. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120142 · Cited by 841 · see citing works

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800 · see citing works

CD47 blockade triggers T cell–mediated destruction of immunogenic tumors

Liu, X., Pu, Y., Cron, K. R., Deng, L., Kline, J. P., Frazier, W. A., Xu, H., Peng, H., Fu, Y., & Xu, M. M. (2015) · Nature Medicine · doi:10.1038/nm.3931 · Cited by 770 · see citing works

The CD47-SIRPα Immune Checkpoint

Logtenberg, M. E. W., Scheeren, F. A., & Schumacher, T. N. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.011 · Cited by 750 · see citing works

Radiotherapy combined with immunotherapy: the dawn of cancer treatment

Zhang, Z., Liu, X., Chen, D., & Yu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01102-y · Cited by 695 · see citing works

Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

Tseng, D., Volkmer, J.-P., Willingham, S. B., Contreras-Trujillo, H., Fathman, J. W., Fernhoff, N. B., Seita, J., Inlay, M. A., Weiskopf, K., Miyanishi, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305569110 · Cited by 656 · see citing works

The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications

Chao, M. P., Weissman, I. L., & Majeti, R. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.01.010 · Cited by 648 · see citing works

Breast cancer stem cells, cytokine networks, and the tumor microenvironment

Körkaya, H., Liu, S., & Wicha, M. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57099 · Cited by 617 · see citing works

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Sikic, B. I., Lakhani, N. J., Patnaik, A., Shah, S. A., Chandana, S. R., Rasco, D. W., Colevas, A. D., O’Rourke, T. J., Narayanan, S., Papadopoulos, K. P., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02018 · Cited by 603 · see citing works

The hallmarks of cancer immune evasion

Galassi, C., Chan, T. A.-T., Vitale, I., & Galluzzi, L. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.09.010 · Cited by 595 · see citing works

The CD47‐SIRPα signaling axis as an innate immune checkpoint in cancer

Matlung, H. L., Szilagyi, K., Barclay, N., & van den Berg, T. K. (2017) · Immunological Reviews · doi:10.1111/imr.12527 · Cited by 563 · see citing works

The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies

Luo, B., & Lee, A. S. (2012) · Oncogene · doi:10.1038/onc.2012.130 · Cited by 559 · see citing works

Targeting immunogenic cell stress and death for cancer therapy

Galluzzi, L., Guilbaud, E., Schmidt, D. R., Kroemer, G., & Marincola, F. M. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00920-9 · Cited by 595 · see citing works

Physiology and diseases of tissue-resident macrophages

Lazarov, T., Juarez-Carreño, S., Cox, N., & Geissmann, F. (2023) · Nature · doi:10.1038/s41586-023-06002-x · Cited by 540 · see citing works

Pharmacological targeting of endoplasmic reticulum stress in disease

Marciniak, S. J., Chambers, J. E., & Ron, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00320-3 · Cited by 536 · see citing works

Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

Overdijk, M. B., Verploegen, S., Bögels, M., van Egmond, M., van Bueren, J. J. L., Mutis, T., Groen, R. W., Breij, E., Martens, A. C., Bleeker, W. K., et al. (2015) · mAbs · doi:10.1080/19420862.2015.1007813 · Cited by 521 · see citing works

Radiotherapy combination opportunities leveraging immunity for the next oncology practice

Herrera, F. G., Bourhis, J., & Coukos, G. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21358 · Cited by 511 · see citing works

SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy

Veillette, A., & Chen, J. (2018) · Trends in Immunology · doi:10.1016/j.it.2017.12.005 · Cited by 476 · see citing works

Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential

Liu, J., Wang, L., Zhao, F., Tseng, S., Narayanan, C., Shura, L., Willingham, S. B., Howard, M., Prohaska, S. S., Volkmer, J. P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137345 · Cited by 479 · see citing works

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

Weiskopf, K., Jahchan, N. S., Schnorr, P. J., Cristea, S., Ring, A. M., Maute, R. L., Volkmer, A. K., Volkmer, J.-P., Liu, J., Lim, J. S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81603 · Cited by 441 · see citing works

Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses

Garg, A. D., & Agostinis, P. (2017) · Immunological Reviews · doi:10.1111/imr.12574 · Cited by 447 · see citing works

An Immunosurveillance Mechanism Controls Cancer Cell Ploidy

Senovilla, L., Vitale, I., Martins, I., Tailler, M., Pailleret, C., Michaud, M., Galluzzi, L., Adjemian, S., Kepp, O., Niso-Santano, M., et al. (2012) · Science · doi:10.1126/science.1224922 · Cited by 436 · see citing works

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

Gholamin, S., Mitra, S. S., Feroze, A. H., Liu, J., Kahn, S. A., Zhang, M., Esparza, R., Richard, C., Ramaswamy, V., Remke, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2968 · Cited by 422 · see citing works

Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing

Gameiro, S. R., Jammeh, M. L., Wattenberg, M. M., Tsang, K. Y., Ferrone, S., & Hodge, J. W. (2013) · Oncotarget · doi:10.18632/oncotarget.1719 · Cited by 421 · see citing works

HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells

Zhang, H., Lu, H., Xiang, L., Bullen, J. W., Zhang, C., Samanta, D., Gilkes, D. M., He, J., & Semenza, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520032112 · Cited by 420 · see citing works

Calreticulin and cancer

Fucikova, J. P., Špíšek, R., Kroemer, G., & Galluzzi, L. (2020) · Cell Research · doi:10.1038/s41422-020-0383-9 · Cited by 408 · see citing works

Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis

Matlung, H. L., Babes, L., Zhao, X. W., van Houdt, M., Treffers, L. W., van Rees, D. J., Franke, K., Schornagel, K., Verkuijlen, P., Janssen, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.082 · Cited by 406 · see citing works

Durable antitumor responses to CD47 blockade require adaptive immune stimulation

Sockolosky, J. T., Dougan, M., Ingram, J. R., Ho, C. C. M., Kauke, M. J., Almo, S. C., Ploegh, H. L., & Garcia, K. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604268113 · Cited by 366 · see citing works

Immunomodulatory Nanosystems

Feng, X.-R., Xu, W.-G., Li, Z., Song, W.-T., Ding, J.-X., & Chen, X.-S. (2019) · Advancement of science · doi:10.1002/advs.201900101 · Cited by 294 · see citing works

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

Li, C., Xu, X., Wei, S., Jiang, P., Xue, L., & Wang, J. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001341 · Cited by 360 · see citing works

Cancer immunotherapy targeting the CD47/SIRPα axis

Weiskopf, K. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.02.013 · Cited by 356 · see citing works

Metal Drugs and the Anticancer Immune Response

Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355 · see citing works

Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis

Zhang, W., Huang, Q., Xiao, W., Zhao, Y., Pi, J., Xu, H., Zhao, H., Xu, J., Evans, C. E., & Jin, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00018 · Cited by 352 · see citing works

Cancer immunoediting by the innate immune system in the absence of adaptive immunity

O’Sullivan, T., Saddawi-Konefka, R., Vermi, W., Koebel, C. M., Arthur, C., White, J. M., Uppaluri, R., Andrews, D. M., Ngiow, S. F., Teng, M. W. L., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112738 · Cited by 348 · see citing works

Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo

Zhang, M., Hütter, G., Kahn, S. A., Azad, T. D., Gholamin, S., Xu, C. Y., Liu, J., Achrol, A. S., Richard, C., Sommerkamp, P., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153550 · Cited by 327 · see citing works

Eaten alive! Cell death by primary phagocytosis: ‘phagoptosis’

Brown, G. C., & Neher, J. J. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.05.002 · Cited by 320 · see citing works

Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy

Wu, J., & Waxman, D. J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.050 · Cited by 319 · see citing works

Immunogenic effects of chemotherapy-induced tumor cell death

Wang, Y., Fletcher, R., Yu, J., & Zhang, L. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.003 · Cited by 316 · see citing works

Chemotherapy induces enrichment of CD47 ⁺ /CD73 ⁺ /PDL1 ⁺ immune evasive triple-negative breast cancer cells

Samanta, D., Park, Y., Ni, X., Li, H., Zahnow, C. A., Gabrielson, E., Pan, F., & Semenza, G. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718197115 · Cited by 302 · see citing works

Tailoring Nanomaterials for Targeting Tumor‐Associated Macrophages

Ovais, M., Guo, M., & Chen, C. (2019) · Advanced Materials · doi:10.1002/adma.201808303 · Cited by 300 · see citing works

SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin

Chen, J., Zhong, M., Guo, H., Davidson, D., Mishel, S., Lü, Y., Rhee, I., Pérez‐Quintero, L., Zhang, S., Cruz‐Munoz, M., et al. (2017) · Nature · doi:10.1038/nature22076 · Cited by 287 · see citing works

Chemotherapy‐induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death

Hodge, J. W., Garnett‐Benson, C., Farsaci, B., Palena, C., Tsang, K.-Y., Ferrone, S., & Gameiro, S. R. (2013) · International Journal of Cancer · doi:10.1002/ijc.28070 · Cited by 283 · see citing works

Emerging phagocytosis checkpoints in cancer immunotherapy

Liu, Y., Wang, Y., Yang, Y., Weng, L., Wu, Q., Zhang, J., Zhao, P., Fang, L., Shi, Y., & Wang, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01365-z · Cited by 287 · see citing works

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding

Petrova, P. S., Viller, N. N., Wong, M., Pang, X., Lin, G. H. Y., Dodge, K., Chai, V., Chen, H., Lee, V., House, V., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1700 · Cited by 277 · see citing works

Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes

Pang, W. W., Pluvinage, J. V., Price, E. A., Sridhar, K., Arber, D. A., Greenberg, P. L., Schrier, S. L., Park, C. Y., & Weissman, I. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222861110 · Cited by 277 · see citing works

Trial watch

Vacchelli, E., Senovilla, L., Eggermont, A. M. M., Fridman, W. H., Galon, J., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.23510 · Cited by 265 · see citing works

Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts

Wang, Y., Zhang, H., Liu, C., Wang, Z., Wu, W., Zhang, N., Zhang, L., Hu, J. J., Luo, P., Zhang, J., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01325-0 · Cited by 261 · see citing works

Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma

Edris, B., Weiskopf, K., Volkmer, A. K., Volkmer, J.-P., Willingham, S. B., Contreras-Trujillo, H., Liu, J., Majeti, R., West, R. B., Fletcher, J. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121629109 · Cited by 258 · see citing works

Harnessing innate immune pathways for therapeutic advancement in cancer

Hu, A.-K., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. Q. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 265 · see citing works

Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk

Feng, M., Chen, J. Y., Weissman-Tsukamoto, R., Volkmer, J.-P., Ho, P. Y., McKenna, K. M., Cheshier, S. H., Zhang, M., Ring, N. G., Gip, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424907112 · Cited by 253 · see citing works

Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies

Chao, M. P., Takimoto, C. H. M., Feng, D. D., McKenna, K. M., Gip, P., Liu, J., Volkmer, J.-P., Weissman, I. L., & Majeti, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01380 · Cited by 254 · see citing works

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

Theruvath, J. L., Menard, M. J., Smith, B. A. H., Linde, M. H., Coles, G. L., Dalton, G. N., Wu, W. E., Kiru, L., Delaidelli, A., Sotillo, E., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01625-x · Cited by 254 · see citing works

CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis

Morrissey, M. A., Kern, N., & Vale, R. D. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.008 · Cited by 252 · see citing works

Autophagy regulation and its role in cancer

Lorin, S., Hamaï, A., Mehrpour, M., & Codogno, P. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.06.007 · Cited by 247 · see citing works

Programmed cell removal: a new obstacle in the road to developing cancer

Chao, M. P., Majeti, R., & Weissman, I. L. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3171 · Cited by 246 · see citing works

Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy

Logtenberg, M. E. W., Jansen, J. H. M., Raaben, M., Toebes, M., Franke, K., Brandsma, A. M., Matlung, H. L., Fauster, A., Gomez, R., Bakker, N. A. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0356-z · Cited by 242 · see citing works

Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity

Roemeling, C. A. V., Wang, Y., Qie, Y., Yuan, H., Hai, Z., Liu, X., Yang, Z., Yang, M., Deng, W., Bruno, K. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15129-8 · Cited by 245 · see citing works

Immunogenic cell death

Garg, A. D., Dudek-Perić, A. M., Romano, E., & Agostinis, P. (2015) · The International Journal of Developmental Biology · doi:10.1387/ijdb.150061pa · Cited by 244 · see citing works

Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms

Sweetwyne, M. T., & Murphy-Ullrich, J. E. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.01.006 · Cited by 239 · see citing works

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

Zhang, P., Rashidi, A., Zhao, J., Silvers, C., Wang, H., Castro, B. A., Ellingwood, A., Han, Y., Lopez‐Rosas, A., Ζαννίκου, Μ., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37328-9 · Cited by 241 · see citing works

A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer

Betancur, P. A., Abraham, B., Yiu, Y. Y., Willingham, S., Khameneh, F., Zarnegar, M. A., Kuo, A. H., McKenna, K., Kojima, Y., Leeper, N., et al. (2017) · Nature Communications · doi:10.1038/ncomms14802 · Cited by 221 · see citing works

Crosstalk between ER stress and immunogenic cell death

Kepp, O., Menger, L., Vacchelli, E., Locher, C., Adjemian, S., Yamazaki, T., Martins, I., Sukkurwala, A. Q., Michaud, M., Senovilla, L., et al. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.05.001 · Cited by 233 · see citing works

Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis

Garg, A. D., Ruysscher, D. D., & Agostinis, P. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1069938 · Cited by 229 · see citing works

Ionizing Radiation-Induced Immune and Inflammatory Reactions in the Brain

Lumniczky, K., Szatmári, T., & Sáfrány, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00517 · Cited by 228 · see citing works

Designing nanomedicine for immuno-oncology

Jiang, W., Roemeling, C. A. V., Chen, Y., Qie, Y., Liu, X., Chen, J., & Kim, B. Y. S. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0029 · Cited by 229 · see citing works

Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 “Don't Eat Me” Signals

McCracken, M. N., Cha, A. C., & Weissman, I. L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2520 · Cited by 225 · see citing works

Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review

Lecoultre, M., Dutoit, V., & Walker, P. R. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001408 · Cited by 223 · see citing works

Diversity and Versatility of Phagocytosis: Roles in Innate Immunity, Tissue Remodeling, and Homeostasis

Lim, J. J., Grinstein, S., & Roth, Z. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00191 · Cited by 217 · see citing works

Blockade of Cd47-Mediated Cathepsin S/Protease-Activated Receptor 2 Signaling Provides a Therapeutic Target for Hepatocellular Carcinoma

Lee, T. K., Cheung, V. C. H., Lu, P., Lau, E. Y.-T., Ma, S., Tang, K. H., Tong, M., Lo, J. H. T., & Ng, I. O. (2014) · Hepatology · doi:10.1002/hep.27070 · Cited by 213 · see citing works

Origin and Consequences of Necroinflammation

Sarhan, M., Land, W. G., Tonnus, W., Hugo, C., & Linkermann, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00041.2016 · Cited by 210 · see citing works

Calreticulin in the immune system: ins and outs

Raghavan, M., Wijeyesakere, S. J., Peters, L. R., & Cid, N. D. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.08.002 · Cited by 204 · see citing works

Nanosecond-Pulsed DBD Plasma-Generated Reactive Oxygen Species Trigger Immunogenic Cell Death in A549 Lung Carcinoma Cells through Intracellular Oxidative Stress

Lin, A. G., Truong, B., Patel, S. H., Kaushik, N. K., Choi, E. H., Fridman, G., Fridman, A., & Miller, V. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050966 · Cited by 201 · see citing works

Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression

Laoui, D., van Overmeire, E., Baetselier, P. D., Ginderachter, J. V. V., & Raes, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00489 · Cited by 199 · see citing works

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma

del Valle, A. S., Anel, A., Naval, J., & Marzo, I. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00050 · Cited by 196 · see citing works

Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy

Chao, M. P., Tang, C. Z., Pachynski, R. K., Chin, R., Majeti, R., & Weissman, I. L. (2011) · Blood · doi:10.1182/blood-2011-02-338020 · Cited by 196 · see citing works

Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review

Russ, A. D., Hua, A., Montfort, W. R., Rahman, B., Riaz, I. B., Khalid, M. U., Carew, J. S., Nawrocki, S. T., Persky, D. O., & Anwer, F. (2018) · Blood Reviews · doi:10.1016/j.blre.2018.04.005 · Cited by 193 · see citing works

Intravenous Delivery of siRNA Targeting CD47 Effectively Inhibits Melanoma Tumor Growth and Lung Metastasis

Wang, Y., Xu, Z., Guo, S., Zhang, L., Sharma, A. K., Robertson, G. P., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2013.135 · Cited by 191 · see citing works

Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes

Wong, D. Y. Q., Ong, W. W. F., & Ang, W. H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500934 · Cited by 186 · see citing works

Immune Priming of the Tumor Microenvironment by Radiation

Jiang, W., Chan, C. K. F., Weissman, I. L., Kim, B. Y. S., & Hahn, S. M. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.09.007 · Cited by 179 · see citing works

Functions of Thrombospondin-1 in the Tumor Microenvironment

Kaur, S., Bronson, S. M., Pal-Nath, D., Miller, T. W., Soto‐Pantoja, D. R., & Roberts, D. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094570 · Cited by 177 · see citing works

CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest

Sick, É., Jeanne, A., Schneider, C., Dedieu, S., Takeda, K., & Martiny, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02099.x · Cited by 173 · see citing works

The immune mechanisms of abscopal effect in radiation therapy

Grass, G. D., Krishna, N., & Kim, S. (2015) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2015.10.003 · Cited by 176 · see citing works

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy

Yuan, H., Jiang, W., Roemeling, C. A. V., Qie, Y., Liu, X., Chen, Y., Wang, Y., Wharen, R. E., Yun, K., Bu, G., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.69 · Cited by 173 · see citing works

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications

Fucikova, J. P., Palová-Jelínková, L., Bartůňková, J., & Špíšek, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02393 · Cited by 172 · see citing works

Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors

Wang, H., Najibi, A. J., Sobral, M. C., Seo, B. R., Lee, J. Y., Wu, D. T. S., Li, A. W., Verbeke, C. S., & Mooney, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-19540-z · Cited by 173 · see citing works

A rapid, automated surface protein profiling of single circulating exosomes in human blood

Kibria, G., Ramos, E. K., Lee, K. E., Bedoyan, S., Huang, S., Samaeekia, R., Athman, J. J., Harding, C. V., Lötvall, J. O., Harris, L. N., et al. (2016) · Scientific Reports · doi:10.1038/srep36502 · Cited by 169 · see citing works

Passion fruit-like exosome-PMA/Au-BSA@Ce6 nanovehicles for real-time fluorescence imaging and enhanced targeted photodynamic therapy with deep penetration and superior retention behavior in tumor

Pan, S., Pei, L., Zhang, A., Zhang, Y., Zhang, C., Huang, M., Huang, Z., Liu, B., Wang, L., Ma, L., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119606 · Cited by 170 · see citing works

Nanoscale Metal–Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy

Ni, K., Luo, T., Culbert, A. A., Kaufmann, M., Jiang, X., & Lin, W. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c05039 · Cited by 167 · see citing works

Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance

Lin, H., Kryczek, I., Li, S., Green, M. D., Ali, A., Hamasha, R., Wei, S., Vatan, L., Szeliga, W., Grove, S., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.023 · Cited by 164 · see citing works

Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk

Feng, M., Chen, J. Y., Weissman-Tsukamoto, R., Volkmer, J.-P., Ho, P. Y., McKenna, K. M., Cheshier, S. H., Zhang, M., Ring, N. G., Gip, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424907112 · Cited by 253 · see citing works

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P. D., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R. K., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,667 · see citing works

A Calreticulin Tail: C-terminal Mutants of Calreticulin Allow Cancer Cells to Evade Phagocytosis

Kaur, A., & Raghavan, M. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.024 · Cited by 5 · see citing works

CD47 masks pro-phagocytic ligands in cis on tumor cells to suppress antitumor immunity

Tang, Z.-H., Zhong, M., Qian, J., Galindo, C. C., Davidson, D., Li, J., Zhao, Y., Hui, E., & Veillette, A. (2023) · Nature Immunology · doi:10.1038/s41590-023-01671-2 · Cited by 66 · see citing works

The Macrophage ‘Do not eat me’ signal, CD47, is a clinically validated cancer immunotherapy target

Takimoto, C. H. M., Chao, M. P., Gibbs, C., Mccamish, M. A., Liu, J., Chen, J. Y., Majeti, R., & Weissman, I. L. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz006 · Cited by 128 · see citing works